The prostate health index selectively identifies clinically significant prostate cancer.
about
Active surveillance for prostate cancer: current evidence and contemporary state of practiceProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersProspective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.Risk stratification of prostate cancer in the modern era.Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian CohortMulticenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy.Biomarkers for prostate cancer: present challenges and future opportunities.An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.Current biomarkers for diagnosing of prostate cancer.Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience.The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.Clinical Utility of Biomarkers in Localized Prostate Cancer.The role of prostate cancer biomarkers in undiagnosed men.Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China.Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.Prostate Health Index density improves detection of clinically significant prostate cancer.Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA rangePredicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.Who and when should we screen for prostate cancer? Interviews with key opinion leaders.Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.Prostate biopsy decisions: one-size-fits-all approach with total PSA is out and a multivariable approach with the Prostate Health Index is in.Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.Summary statement on screening for prostate cancer in Europe.Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.Fascin is secreted in male's serum: results of a pilot study.Prostate Cancer Screening.Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening GuidelinesProstate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
P2860
Q28066534-6AD1AA1E-548E-4F58-B4A9-11311380C92BQ28075610-180B0469-ECDD-4E8F-B2B1-6E468B2A6456Q33668692-53D907B2-3709-4AE2-9E14-7590543C479EQ35680101-2D872AC0-F9F3-4360-9600-323297570A61Q36238237-3AE112B4-9F29-4364-B74D-CF8D9153ADDBQ36416441-3DF6494C-6804-4FCB-9388-8023D171F611Q37206050-C0546587-E425-4BD8-B5FD-10B17E954EBDQ37474443-A2BBAFF8-4F8D-48D6-9B52-B42B7DE618A8Q37691113-CBD00DFE-3460-45D3-B80E-6D93CBBB5D4EQ38584370-017543D6-AF49-4EA5-9F15-33FD146A8542Q38626590-BF85B058-76A1-4398-932E-6BBADAF58163Q38684598-63C26C38-FAB2-4A7F-92A3-1492B11F7E62Q38741968-6E2FA78A-F405-4778-907B-C00F2FF9D135Q38792354-FE57E9DA-545D-4F2D-8871-FBDB897516F7Q39140686-79B33846-96FF-4926-9073-66E6CEAC5BE6Q40140207-3FD64DE4-9B24-4C3E-B8E6-EBCF4B247961Q40404113-DB21C41B-80BE-4B78-852E-9904061C0DCEQ40412845-79D3440B-2646-438B-95AE-40692A16BFAFQ40433157-0A7938A4-3739-4B0C-93AF-4E4A37E9AA68Q40438258-92DA55B2-E0F4-4D47-84EB-32CD2EAAEB6AQ40541815-3E4F9528-04EE-4312-9424-7C4DDEFBEEAFQ42231619-99DC7496-89C0-415D-8B82-13FC79660185Q43152601-47CB0B67-BCD8-4ED0-A839-1C1A69627279Q43169980-AE87CE8A-C071-4A56-901E-C86DE0894E96Q47098249-7517F4EB-41A9-4BF0-BEC0-3D743B2FAADCQ47123251-B82EA2AC-66AB-48BD-976A-2240AE55D579Q47303003-303E92C1-6B8F-4D45-BF8C-4D0E98F2CE81Q47382349-B0012391-4D72-40ED-92BA-86FFA0E8CA77Q47436741-E9DB5279-6E66-48CE-98AF-33BB006FE9DBQ47901606-5199B20C-1BE0-42EA-A30A-FF877780FE65Q49710514-FAC6346F-02BE-4FBD-81D6-A219166FF2E5Q51781558-542DF687-7709-4CEB-87B7-1B4257BB9E66Q52641462-98454732-CD5E-43E2-8B0A-BD32F7308F46Q52698894-BC9012E7-103E-4D5C-B85E-10A50796EE2EQ54986662-BE47E016-B857-4849-9279-BACC7227373BQ57150651-A51F065B-C6C0-48F5-BE4F-99EDA60131C3Q58799069-2A2F8ACC-88E7-44FC-AD63-BF724D5B8743
P2860
The prostate health index selectively identifies clinically significant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The prostate health index selectively identifies clinically significant prostate cancer.
@ast
The prostate health index selectively identifies clinically significant prostate cancer.
@en
type
label
The prostate health index selectively identifies clinically significant prostate cancer.
@ast
The prostate health index selectively identifies clinically significant prostate cancer.
@en
prefLabel
The prostate health index selectively identifies clinically significant prostate cancer.
@ast
The prostate health index selectively identifies clinically significant prostate cancer.
@en
P2093
P2860
P1476
The prostate health index selectively identifies clinically significant prostate cancer.
@en
P2093
Amabelle B Cruz
Chris H Bangma
Daniel W Chan
Dennis L Broyles
George G Klee
Isaac A Mizrahi
John T Wei
Kevin M Slawin
Leonard S Marks
Lori J Sokoll
P2860
P304
P356
10.1016/J.JURO.2014.10.121
P407
P577
2014-11-15T00:00:00Z